QT
AUPH icon

Quantamental Technologies’s Aurinia Pharmaceuticals AUPH Stock Holding History

Quantamental Technologies’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,469
Closed -$159K – 475
2023
Q1 		$159K Buy
+14,469
New +$127K 0.09% 364

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Quantamental Technologies's AUPH Position: Q2 2023 in Review

Quantamental Technologies sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2023, closing a stake of 14,469 shares — an estimated $159K sold.

Quantamental Technologies first reported a position in AUPH in Q1 2023 and held it in 1 quarter. The position peaked at $159K in Q1 2023. 200 funds tracked by Wall St. Rank hold AUPH as of Q2 2023.

  • Quantamental Technologies reported no remaining Aurinia Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Quantamental Technologies sold 14,469 Aurinia Pharmaceuticals shares in Q2 2023, an estimated $159K.
  • Quantamental Technologies first reported a position in Aurinia Pharmaceuticals in Q1 2023 and held it in 1 quarter.
  • Quantamental Technologies's Aurinia Pharmaceuticals position peaked at $159K in Q1 2023.
  • 200 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2023.

Based on Quantamental Technologies's 13F filing for Q2 2023, filed 14 Aug 2023.